A Study Of AL101 In Patients with Adenoid Cystic Carcinoma Bearing Activating Notch Mutations
Rochester, MN
The primary purpose of this study is to assess the clinical activity of AL101 using radiographic assessments and Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 in Adenoid Cystic Carcinoma (ACC) patients with activating Notch mutations.